Human donor blood for bioassay development

Ended Purchase Order Awarded Last action

Contract number
75F40124P00405
Awardee
Awarding agency
Obligated
$47,440

Award facts

Opportunity
Contract value 100% obligated
$47,440.00 Current and potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Contracting staff
NAICS code
621991 Blood and Organ Banks
Set-aside
No set-aside
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Folsom, CA 95630, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00001 · The purpose of this modification is to DE-obligate excess funds and close out the contract. -$30
Original award $47,470

About this award

The Food and Drug Administration awarded a purchase order to Stemexpress, LLC, a small disadvantaged woman-owned business, for human donor blood for bioassay development, with a ceiling value of $47,440.00 and an award date of September 6, 2024. Work is performed in Folsom, California. The order, issued under firm fixed-price terms without set-aside designation, calls for peripheral blood mononuclear cells and isolated immune cells to support FDA bioassay development initiatives. The contract was closed out on July 28, 2026, with excess funds de-obligated.

Quick answers

Who was awarded contract 75F40124P00405?

75F40124P00405 was awarded to Stemexpress, LLC by Food and Drug Administration (Department of Health and Human Services) on September 6, 2024.

How much is contract 75F40124P00405 worth?

The government has obligated $47,440 on 75F40124P00405.

Was contract 75F40124P00405 competed?

The extent of competition for 75F40124P00405 was competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award